Genetic disruption of the EP1 receptor is reported to blunt the acute pressor response to Ang II as well as to reduce chronic Ang II-driven hypertension.114 Also, oral administration of an EP1 receptor antagonist reduced blood pressure in spontaneously hypertensive rats. Here, AGT is linked to hypertensive disorder.